Citadel Advisors
ORGO icon

Citadel Advisors’s Organogenesis Holdings ORGO Stock Holding History

Citadel Advisors’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-39,700
Closed -$168K – 13688
2025
Q3 		$168K Buy
39,700
+24,600
+163% +$114K ﹤0.01% 11439
2025
Q2 		$55.3K Sell
15,100
-200
-1% -$745 ﹤0.01% 11722
2025
Q1 		$66.1K Buy
15,300
+11,000
+256% +$44.4K ﹤0.01% 11996
2024
Q4 		$13.8K Buy
+4,300
New +$14.4K ﹤0.01% 13432
2024
Q3 		– Sell
-3,800
Closed -$10.6K – 14946
2024
Q2 		$10.6K Sell
3,800
-6,600
-63% -$17.7K ﹤0.01% 13076
2024
Q1 		$29.5K Sell
10,400
-11,400
-52% -$38.7K ﹤0.01% 12709
2023
Q4 		$89.2K Buy
21,800
+18,200
+506% +$51K ﹤0.01% 11070
2023
Q3 		$11.4K Sell
3,600
-3,000
-45% -$9.53K ﹤0.01% 13008
2023
Q2 		$21.9K Sell
6,600
-1,100
-14% -$3.25K ﹤0.01% 12649
2023
Q1 		$16.4K Sell
7,700
-2,000
-21% -$4.94K ﹤0.01% 13205
2022
Q4 		$26.1K Sell
9,700
-9,500
-49% -$27.7K ﹤0.01% 12898
2022
Q3 		$62K Buy
19,200
+6,200
+48% +$28K ﹤0.01% 11475
2022
Q2 		$63K Sell
13,000
-15,600
-55% -$96K ﹤0.01% 11780
2022
Q1 		$218K Buy
28,600
+4,900
+21% +$37.9K ﹤0.01% 11318
2021
Q4 		$219K Sell
23,700
-8,400
-26% -$89.2K ﹤0.01% 11653
2021
Q3 		$457K Buy
32,100
+8,300
+35% +$129K ﹤0.01% 10092
2021
Q2 		$396K Buy
23,800
+4,300
+22% +$80.2K ﹤0.01% 10591
2021
Q1 		$355K Buy
+19,500
New +$264K ﹤0.01% 10455

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Citadel Advisors's ORGO Position: Q1 2026 in Review

Citadel Advisors reduced its Organogenesis Holdings (ORGO) stake by 4.4% in Q1 2026, selling an estimated $86.4K and leaving 544,235 shares worth $1.29M. The position accounts for ﹤0.01% of the portfolio, ranked #7090.

Citadel Advisors first reported a position in ORGO in Q2 2019 and has held it in 25 quarters since. The position peaked at $9.81M in Q2 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • Citadel Advisors held 544,235 shares of Organogenesis Holdings worth $1.29M as of Q1 2026.
  • Citadel Advisors sold 24,931 Organogenesis Holdings shares in Q1 2026, an estimated $86.4K.
  • Organogenesis Holdings made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #7090 holding.
  • Citadel Advisors first reported a position in Organogenesis Holdings in Q2 2019 and has held it in 25 quarters since.
  • Citadel Advisors's Organogenesis Holdings position peaked at $9.81M in Q2 2021.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.